Kidswell Bio Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Kidswell Bio's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs Industry Growth | 31.9% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Next Earnings Update | 14 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Kidswell Bio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 1,877 | -302 | 844 | 959 |
| 31 Mar 22 | 1,569 | -535 | 787 | 1,150 |
| 31 Dec 21 | 1,659 | -425 | 788 | 1,133 |
| 30 Sep 21 | 1,562 | -768 | 852 | 1,092 |
| 30 Jun 21 | 1,178 | -1,071 | 861 | 1,121 |
| 31 Mar 21 | 996 | -1,001 | 883 | 963 |
| 31 Dec 20 | 1,064 | -1,094 | 833 | 813 |
| 30 Sep 20 | 938 | -1,462 | 745 | 817 |
| 30 Jun 20 | 915 | -1,413 | 721 | 802 |
| 31 Mar 20 | 1,077 | -7,316 | 687 | 898 |
| 31 Dec 19 | 1,136 | -7,224 | 669 | 1,105 |
| 30 Sep 19 | 1,046 | -7,059 | 607 | 1,144 |
| 31 Mar 19 | 1,022 | -856 | 469 | 945 |
| 31 Dec 18 | 901 | -915 | 445 | 976 |
| 30 Sep 18 | 901 | -824 | 437 | 892 |
| 30 Jun 18 | 981 | -864 | 440 | 1,000 |
| 31 Mar 18 | 1,060 | -905 | 443 | 1,107 |
| 31 Dec 17 | 1,077 | -724 | 445 | 942 |
| 30 Sep 17 | 1,046 | -849 | 445 | 1,070 |
| 30 Jun 17 | 1,067 | -1,037 | 444 | 1,252 |
| 31 Mar 17 | 1,089 | -1,225 | 443 | 1,433 |
| 30 Sep 16 | 860 | -1,491 | 450 | 1,539 |
| 30 Jun 16 | 1,010 | -1,139 | 428 | 1,307 |
| 31 Mar 16 | 1,161 | -788 | 405 | 1,075 |
| 31 Mar 15 | 322 | -792 | 308 | 690 |
Quality Earnings: Insufficient data to determine if 4584 has high quality earnings.
Growing Profit Margin: Insufficient data to determine if 4584's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 4584's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare 4584's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if 4584's earnings growth over the past year exceeded the Biotechs industry average.
Return on Equity
High ROE: 4584 has a negative Return on Equity (0%), as it is currently unprofitable.